As of 2024-12-13, the EV/EBITDA ratio of Precigen Inc (PGEN) is -2.10. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PGEN's latest enterprise value is 194.99 mil USD. PGEN's TTM EBITDA according to its financial statements is -92.86 mil USD. Dividing these 2 quantities gives us the above PGEN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 15.2x - 19.4x | 17.2x |
| Forward P/E multiples | 15.8x - 29.8x | 22.4x |
| Fair Price | (4.91) - (6.06) | (6.19) |
| Upside | -754.8% - -907.8% | -924.5% |
| Date | EV/EBITDA |
| 2024-12-09 | -2.27 |
| 2024-12-06 | -2.18 |
| 2024-12-05 | -2.17 |
| 2024-12-04 | -2.27 |
| 2024-12-03 | -2.46 |
| 2024-12-02 | -2.60 |
| 2024-11-29 | -2.67 |
| 2024-11-27 | -2.60 |
| 2024-11-26 | -2.45 |
| 2024-11-25 | -2.67 |
| 2024-11-22 | -2.58 |
| 2024-11-21 | -2.58 |
| 2024-11-20 | -2.37 |
| 2024-11-19 | -2.24 |
| 2024-11-18 | -2.23 |
| 2024-11-15 | -2.32 |
| 2024-11-14 | -2.52 |
| 2024-11-13 | -2.62 |
| 2024-11-12 | -2.73 |
| 2024-11-11 | -2.89 |
| 2024-11-08 | -2.81 |
| 2024-11-07 | -2.73 |
| 2024-11-06 | -2.56 |
| 2024-11-05 | -2.33 |
| 2024-11-04 | -2.30 |
| 2024-11-01 | -2.31 |
| 2024-10-31 | -2.22 |
| 2024-10-30 | -2.33 |
| 2024-10-29 | -2.39 |
| 2024-10-28 | -2.40 |
| 2024-10-25 | -2.41 |
| 2024-10-24 | -2.57 |
| 2024-10-23 | -2.70 |
| 2024-10-22 | -2.69 |
| 2024-10-21 | -2.66 |
| 2024-10-18 | -2.74 |
| 2024-10-17 | -2.62 |
| 2024-10-16 | -2.59 |
| 2024-10-15 | -2.48 |
| 2024-10-14 | -2.58 |
| 2024-10-11 | -2.57 |
| 2024-10-10 | -2.37 |
| 2024-10-09 | -2.41 |
| 2024-10-08 | -2.43 |
| 2024-10-07 | -2.41 |
| 2024-10-04 | -2.57 |
| 2024-10-03 | -2.64 |
| 2024-10-02 | -2.78 |
| 2024-10-01 | -2.72 |
| 2024-09-30 | -2.72 |